AU2002221553A1 - Vaccines containing recombinant hantavirus proteins, methods for producing said vaccines and their use - Google Patents

Vaccines containing recombinant hantavirus proteins, methods for producing said vaccines and their use

Info

Publication number
AU2002221553A1
AU2002221553A1 AU2002221553A AU2155302A AU2002221553A1 AU 2002221553 A1 AU2002221553 A1 AU 2002221553A1 AU 2002221553 A AU2002221553 A AU 2002221553A AU 2155302 A AU2155302 A AU 2155302A AU 2002221553 A1 AU2002221553 A1 AU 2002221553A1
Authority
AU
Australia
Prior art keywords
vaccines
producing
methods
containing recombinant
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221553A
Inventor
Ausra Dargeviciute
ake Lundkvist
Kestutis Sasnauskas
Rainer Ulrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INSTITUTE OF BIOTECHNOLOGY
Original Assignee
Humboldt Universitaet zu Berlin
Universitatsklinikum Charite Berlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Humboldt Universitaet zu Berlin, Universitatsklinikum Charite Berlin filed Critical Humboldt Universitaet zu Berlin
Publication of AU2002221553A1 publication Critical patent/AU2002221553A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12111—Hantavirus, e.g. Hantaan virus
    • C12N2760/12122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2002221553A 2000-11-08 2001-11-07 Vaccines containing recombinant hantavirus proteins, methods for producing said vaccines and their use Abandoned AU2002221553A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10055886.0 2000-11-08
DE10055886A DE10055886A1 (en) 2000-11-08 2000-11-08 Vaccines containing recombinant hantavirus proteins, processes for their preparation and their use
PCT/DE2001/004213 WO2002038174A2 (en) 2000-11-08 2001-11-07 Vaccines containing recombinant hantavirus proteins, methods for producing said vaccines and their use

Publications (1)

Publication Number Publication Date
AU2002221553A1 true AU2002221553A1 (en) 2002-05-21

Family

ID=7662912

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221553A Abandoned AU2002221553A1 (en) 2000-11-08 2001-11-07 Vaccines containing recombinant hantavirus proteins, methods for producing said vaccines and their use

Country Status (3)

Country Link
AU (1) AU2002221553A1 (en)
DE (1) DE10055886A1 (en)
WO (1) WO2002038174A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8333918B2 (en) 2003-10-27 2012-12-18 Kimberly-Clark Worldwide, Inc. Method for the production of nonwoven web materials
CN101249261B (en) * 2008-03-18 2010-10-27 中国疾病预防控制中心病毒病预防控制所 Kidney syndrome hemorrhagic fever mucosa immune vaccines and method of preparing the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7179094A (en) * 1993-06-24 1995-01-17 United States Of America, As Represented By The Secretary, Department Of Health And Human Services Nucleic acids of a novel hantavirus and reagents for detection and prevention of infection
US5916754A (en) * 1995-02-17 1999-06-29 The United States Of America As Represented By The Department Of Health And Human Services Bayou hantavirus and related methods
US5879968A (en) * 1996-11-18 1999-03-09 International Rectifier Corporation Process for manufacture of a P-channel MOS gated device with base implant through the contact window
WO1999001153A1 (en) * 1997-07-03 1999-01-14 The University Of New Mexico Rio mamore hantavirus
DE19750220A1 (en) * 1997-11-13 1999-05-20 Max Delbrueck Centrum Producing polyoma virus-like particles in yeast for gene therapy, vaccine development and diagnosis
ATE335506T1 (en) * 1999-01-29 2006-09-15 U S Medical Res Inst Of Infect DNA VACCINES AGAINST HANTAVIRUS INFECTIONS

Also Published As

Publication number Publication date
DE10055886A1 (en) 2002-05-29
WO2002038174A3 (en) 2003-08-28
WO2002038174A2 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
HUP0201783A2 (en) Anti-alfavbetha3 recombinant human antibodies, nucleic acids encoding same and methods
EP2940044B8 (en) Anti-tnf alpha antibodies for use in therapy
MXPA03007323A (en) Artificial proteins with reduced immunogenicity.
PT1361893E (en) Modified anti-egfr antibodies with reduced immunogenicity
AU2002353790A1 (en) Syringe and reconstitution syringe
HUP0401753A3 (en) Antigen presenting cells, method for their preparation and their use for cancer vaccines
AU2002255952A1 (en) Short bioactive peptides and methods for their use
AU2001256373A1 (en) Syringe and method for the use thereof
IL153539A0 (en) Protein complexes and methods for the preparation thereof
AU2001282037A1 (en) Proton-translocating retinal protein
AU2002233407A1 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
IL156647A0 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
AU2002312373A1 (en) Structural and cytoskeleton-associated proteins
AU2002341828A1 (en) Enhanced proteins and methods for their use
IL145440A0 (en) Synthetic hcv envelope proteins and their use for vaccination
AU2002221553A1 (en) Vaccines containing recombinant hantavirus proteins, methods for producing said vaccines and their use
AU2001242750A1 (en) Novel protein, process for producing the same and use thereof
GB0217548D0 (en) Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12
AU2002252773A1 (en) Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
AU2002241570A1 (en) Human proteins, polynucleotides encoding them and methods of using the same
AU2002224199A1 (en) Methods and means for producing proteins with predetermined post-translational modifications
AU2001265830A1 (en) Solubilised protein vaccines
EP1578906A4 (en) Afap sequences, polypeptides, antibodies and methods
AU2002316348A1 (en) Chimeric capsid proteins and uses thereof
AU2002343516A1 (en) Structural and cytoskeleton-associated proteins